India, Dec. 29 -- Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement withIntegriMedical,the technology leader behind India's first Needle-Free Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynecology treatments across India.

This marks a significant milestone in IVF and women's health. Securing exclusivity for a first-of-its-kind needle-free injector transforms both the delivery and experience of treatment, placing patient comfort and confidence at the forefront of care.

Through this agreement, Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections, setting a new benchmark for patient-centric innovative drug ...